56.4 percent of cancer survivors report having one or more conditions, with increased prevalence in Black survivors
WEDNESDAY, Feb. 3, 2021 (HealthDay News) — More than half of cancer survivors have underlying medical conditions associated with severe COVID-19 illness, including chronic obstructive pulmonary disease, heart diseases, diabetes, chronic kidney disease, and obesity, according to a study published online Feb. 3 in the Journal of the National Cancer Institute.
Changchuan Jiang, M.D., M.P.H., from the Roswell Park Comprehensive Cancer Center in Buffalo, New York, and colleagues examined the prevalence and sociodemographic factors associated with underlying medical conditions that are linked to an increased risk for severe COVID-19 illness among 6,411 cancer survivors and 77,748 adults without a cancer history.
The researchers found that 56.4 percent of cancer survivors reported having one or more of the conditions (compared with 41.6 percent among adults without a cancer history) and 22.9 percent of survivors reported two or more conditions, representing 8.7 and 3.5 million cancer survivors, respectively. The prevalence of these conditions was increased among survivors of kidney, liver, and uterine cancers and among Black survivors, those with public insurance, and those with low socioeconomic status.
“Underlying medical conditions related to severe COVID-19 illness are common among cancer survivors, highlighting the need to protect this vulnerable population against transmission in health care facilities,” the authors write. “Now that safe and effective COVID-19 vaccines are available, cancer patients, survivors, caregivers, and their health care providers should be prioritized in vaccine allocation.”
One author disclosed financial ties to AstraZeneca.
Risk for Ischemic Stroke Increased After Cancer Diagnosis
Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S.
Cancer Risk ID"d for Asian American, NHPI Population
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths
Combo of Step Count and Step Pace Tied to Lower Risk for Early Death
Recommendations Updated for Radiation Therapy in Pancreatic Cancer
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors